The authors report complete remission of digital ischemia, blanching, ulceration, pain, and poor fingernail growth associated with Raynaud's phenomenon in a thirty-one-year-old, nondepressed woman treated with fluoxetine.
Get full access to this article
View all access options for this article.
References
1.
Biondi ML, Marasini B., Bianchi E., et al: Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol19:335-339, 1988.
2.
Altomare GF, Pigatto PD, Polenghi MM: Ketanserin in the treatment of progressive systemic sclerosis. Angiology39:583-586, 1988.
3.
Langevitz P., Buskila D., Lee P., et al: Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE, infusions. J Rheumatol16:1433-1435, 1989.
4.
Ameklo-Nobin B., Elmer O., Akesson A.: Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. Int Angio7:19-25, 1988.
5.
Pigott TA, Pato MT, Berstein S., et al: Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry47:926-932, 1990.
6.
Hamilton M.: Development of a rating scale for primary depressive illness. Br J Soc andClin Psychol6:278-296, 1967.
